tradingkey.logo
tradingkey.logo
Suchen

SBC Medical Group Holdings Inc

SBC
Zur Watchlist hinzufügen
3.250USD
+0.080+2.52%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
333.38MMarktkapitalisierung
8.19KGV TTM

mehr Informationen über SBC Medical Group Holdings Inc Unternehmen

SBC Medical Group Holdings Incorporated is a management company, which owns, operates, and provides management services to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

SBC Medical Group Holdings Inc Informationen

BörsenkürzelSBC
Name des UnternehmensSBC Medical Group Holdings Inc
IPO-datumSep 26, 2022
CEOAikawa (Yoshiyuki)
Anzahl der mitarbeiter863
WertpapierartOrdinary Share
GeschäftsjahresendeSep 26
Addresse200 Spectrum Center Dr.
StadtIRVINE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92618
Telefon19495930250
Websitehttps://ir.sbc-holdings.com/
BörsenkürzelSBC
IPO-datumSep 26, 2022
CEOAikawa (Yoshiyuki)

Führungskräfte von SBC Medical Group Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Dr. Mike Sayama, Ph.D.
Dr. Mike Sayama, Ph.D.
Independent Director
Independent Director
--
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Akira Komatsu
Mr. Akira Komatsu
Secretary
Secretary
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--
Ms. Miki (Shimizu) Yamazaki
Ms. Miki (Shimizu) Yamazaki
Chief Strategy Officer
Chief Strategy Officer
--
--
Mr. Shinya Inoue
Mr. Shinya Inoue
Chief Marketing Officer
Chief Marketing Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Yoshiyuki Aikawa
Dr. Yoshiyuki Aikawa
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
83.84M
--
Dr. Mike Sayama, Ph.D.
Dr. Mike Sayama, Ph.D.
Independent Director
Independent Director
--
--
Mr. Yuya Yoshida
Mr. Yuya Yoshida
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
--
--
Mr. Akira Komatsu
Mr. Akira Komatsu
Secretary
Secretary
--
--
Mr. Ken Edahiro
Mr. Ken Edahiro
Independent Director
Independent Director
--
--
Mr. Fumitoshi Fujiwara
Mr. Fumitoshi Fujiwara
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von SBC Medical Group Holdings Inc?

Die fünf größten Anteilseigner von SBC Medical Group Holdings Inc sind: Dr. Yoshiyuki Aikawa

Wie viele Institutionen halten Anteile an SBC Medical Group Holdings Inc (SBC)?

Mit Stand vom 2026Q1 halten 90 Institutionen Anteile an SBC Medical Group Holdings Inc, mit einem Gesamtmarktwert von etwa 1.60M, was 1.56% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 465540.00 gestiegen.

Was ist die größte Einnahmequelle von SBC Medical Group Holdings Inc?

Am 2026Q1 erzielte das Geschäft mit Procurement services für SBC Medical Group Holdings Inc den höchsten Umsatz in Höhe von 56.05M, was 32.29% des Gesamtumsatzes entspricht.